Glipizide :
1-Cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]urea ; CAS : 29094-61-9 ; C21H27N5O4S ; MW: 445.54 ; |
Glipizide Impurity A :
[2-(4-Sulphamoylphenyl) ethyl] 5-methyl-pyrazine-2-carboxamide ; CAS : 33288-71-0 ; C14H16N4O3S ; MW: 320.37 ; |
Glipizide Impurity B :
Cyclohexylamine HBr ; CAS : 108-91-8 (base) ; 4998-76-9 (HCl salt) ; 26227-54-3 (HBr salt) ; C6H13N (base) ; MW: 99.17 ; C6H14BrN (HBr salt) ; MW: 180.09 ; |
Glipizide Impurity C :
Ethyl 2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl]carbamate ; CAS : 13554-93-3 ; C18H27N3O5S ; MW: 397.49 ; |
Glipizide Impurity D :
6-Methyl-N-[2-(4-sulfamoylphenyl)-ethyl]pyrazine-2-carboxamide ; CAS : 1346600-54-1 ; C14H16N4O3S ; MW: 320.37 ; |
Glipizide Impurity E :
5-Desmethyl-6-Methyl Glipizide ; Glipizide 6-Methyl Analog ; CAS : 66375-96-0 ; C21H27N5O4S ; MW: 445.54 ; |
Glipizide Impurity F :
[2-[4-(Aminosulfonyl)phenyl]ethyl]carbamic acid ethyl ester ; CAS : 192118-08-4 ; C11H16N2O4S ; MW: 272.32 ; |
Glipizide Impurity G:
Methyl 4-[β-(5-Methylpyrazine-2-carboxamido)ethyl]benzene sulfonamide carbamate ; CAS : 33288-74-3 ; C16H18N4O5S ; MW: 378.4 ; |
Glipizide Impurity H :
1-Cyclohexyl-3-(p-sulfamoylphenethyl)urea ; CAS : 10080-05-4 ; C15H23N3O3S ; MW: 325.43 ; |
Glipizide Impurity I :
N1-[4-(β-Cyclohexylureidoethyl)benzensulfonyl] N3-cyclohexylurea ; CAS : 10079-35-3 ; C22H34N4O4S ; MW: 450.59 ; |